The National Farmers' Union (NFU) has recently called for enhanced biosecurity measures among farmers after detecting a case of avian influenza (H5N1) in a sheep in Yorkshire. This discovery came to light following routine surveillance, wherein avian influenza had previously been confirmed in
The notion of genetically engineering an unborn child's sexual orientation has stirred debates among ethicists, scientists, and religious groups. This discourse stems from the suggestion that, with advancements in scientific knowledge, it might be possible to determine an unborn child's sexual
The COVID-19 pandemic underscored significant challenges that tested the resilience of the global biotech industry, causing unprecedented disruptions but also highlighting areas ripe for growth and innovation. Against this backdrop, the Gulf Cooperation Council (GCC) countries, with Saudi Arabia at
GRObio, a spinout from the George Church Lab at Harvard University, has encountered significant hurdles lately. Founded in 2016, GRObio focuses on developing therapeutic proteins built on nonstandard amino acids (NSAAs). Despite its pioneering approach, the company is undergoing a period of
Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. He joins us today to discuss Ori Biotech’s new Preferred Partner Network (PPN), the collaboration with various organizations, and the impacts on cell therapy
Bioprinting has emerged as a revolutionary bioengineering technique that utilizes the principles of 3D printing to create tissue-like structures embedded with living cells. Since its inception in 1988, this technology has experienced tremendous growth, advancing from its original concept to today’s